Skip to main content
Signal8
FITZGERALD EDWARD M profile photo

Edward M. Fitzgerald

CIK: 0001242993

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Parabilis Medicines, Inc. logo
PBLS

Parabilis Medicines, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Parabilis Medicines, Inc. logo
    PBLS

    Parabilis Medicines, Inc.

    Jun 11, 2026
    Conversion(C)
    Direct
    5.5K shares-
  • Parabilis Medicines, Inc. logo
    PBLS

    Parabilis Medicines, Inc.

    Jun 11, 2026
    Conversion(C)
    Direct
    3.9K shares-
  • Parabilis Medicines, Inc. logo
    PBLS

    Parabilis Medicines, Inc.

    Jun 11, 2026
    Conversion(C)
    Direct
    5.3K shares-
  • Parabilis Medicines, Inc. logo
    PBLS

    Parabilis Medicines, Inc.

    Jun 9, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    20.2K shares-

1-4 of 4

About FITZGERALD EDWARD M

FITZGERALD EDWARD M (SEC CIK 0001242993) files insider reports with the SEC as Director of Parabilis Medicines, Inc. (PBLS).

Signal8 holds 3 ownership filings by FITZGERALD EDWARD M (1 Form 3, 2 Form 4), filed between Jun 9, 2026 and Jun 15, 2026. Those filings report 4 transactions, from Jun 9, 2026 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FITZGERALD EDWARD M's filings is in CAMBRIDGE, MA.

Recent filings by FITZGERALD EDWARD M

  • Jun 11, 2026: Conversions of PBLS shares (3 lines, Form 4, code C).
  • Jun 9, 2026: Grant or award of PBLS derivative securities (Form 4, code A).

Other insiders filing for Parabilis Medicines, Inc. (PBLS)

How to read Form 4 transaction codes